Senti Bio (SNTI)science reported positive initial clinical data from a Phase 1 clinical trial of SENTI-202, a potential first-in-class Logic Gated off-the-shelf chimeric antigen receptor natural kille ...
The global bio plasticizers market revenue was around US$1.4 billion in 2023 and is estimated to reach US$ 2.3 billion by 2032, growing at a compound annual growth rate (CAGR) of 5.5% during the ...